Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-016140 General Corporate
Debt relative to revenue 100th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.debt_to_revenue
105.63% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.76% · OPTIONAL · VALID
Operating cash generation 77th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
6.64% · OPTIONAL · VALID
Revenue growth 67th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
21.03% · CORE · VALID
Inventory pressure 31th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
94.30% · OPTIONAL · VALID
Gross margin 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
25.12% · CORE · VALID
Operating margin 77th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
6.70% · CORE · VALID
R&D intensity 31th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.74% · OPTIONAL · VALID
SBC intensity 58th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.45% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 33.44%
Current 105.63%
Delta 72.19% Capex Intensity Increased
Previous 1.17%
Current 1.76%
Delta 0.59% Cash Generation Decreased
Previous 10.12%
Current 6.64%
Delta -3.48% Growth Increased
Previous 3.66%
Current 21.03%
Delta 17.37% Inventory Pressure Increased
Previous 31.23%
Current 94.30%
Delta 63.07% Margin Decreased
Previous 25.73%
Current 25.12%
Delta -0.61% Profitability Increased
Previous 6.06%
Current 6.70%
Delta 0.64% R And D Intensity Decreased
Previous 5.03%
Current 4.74%
Delta -0.29% Sbc Intensity Increased
Previous 0.42%
Current 0.45%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.